Landscape Assessment and Policy Recommendations: Scaling Nucleic Acid-based Biopharmaceutical Technologies in Asia and the Pacific

Event: Blueprints to Breakthroughs: Enhancing Vaccine Manufacturing Ecosystems in DMCs

Landscape Assessment and Policy Recommendations: Scaling Nucleic Acid-based Biopharmaceutical Technologies in Asia and the Pacific

24 October 2024

Author / Speaker:

Ragini Ahluwalia, Accenture Development Partnerships - Other materials by the author

Varun Srivastava, Accenture Development Partnerships' Global Health - Other materials by the author

View Slides

This presentation gives an overview of the landscape assessment and policy recommendations for scaling nucleic acid-based biopharmaceutical technologies in Asia and Pacific region, with a focus on market assessment, technology overview, and capacity building policy briefs for Bangladesh.

Type of Content:

Learning Event

Disclaimer

The views expressed on this website are those of the authors and do not necessarily reflect the views and policies of the Asian Development Bank (ADB) or its Board of Governors or the governments they represent. ADB does not guarantee the accuracy of the data included in this publication and accepts no responsibility for any consequence of their use. By making any designation of or reference to a particular territory or geographic area, or by using the term “country” in this document, ADB does not intend to make any judgments as to the legal or other status of any territory or area.